| mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |
| mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
| mRNA |
FMK |
GDSC1000 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
| mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
| mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.9 |
| mRNA |
PHA-665752 |
GDSC1000 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
| mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
0.0051 |
0.9 |
| mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |
| mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0032 |
0.9 |
| mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |